Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 2/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.41 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.41 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.41 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | AVPR1A | P37288 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | EP300 | Q09472 | 1/20 | 0.33 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30298041 | 0.82 | GRIN2D (0.41) | GRIN1GRIN2BGRIN2DGRIN3BGRIN2A | |
| SCHEMBL1977844 | 0.76 | CD274 (0.45) | PLD1CRBNALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL28286321 | 0.73 | HPGD (0.39) | ALDH1A1SMN1; SMN2LMNAGAAPOLB | |
| SCHEMBL4071380 | 0.72 | HPGD (0.38) | ALDH1A1SMN1; SMN2LMNAGAAPOLB | |
| SCHEMBL4148701 | 0.72 | HPGD (0.38) | ALDH1A1SMN1; SMN2LMNAGAAPOLB | |
| SCHEMBL6024373 | 0.68 | SMN1; SMN2 (0.47) | GRIN1GRIN2BGRIN2DGRIN3BGRIN2A | |
| SCHEMBL374979 | 0.66 | ALDH1A1 (0.33) | ALDH1A1MAPTSMN1; SMN2KDM4EPOLB | |
| SCHEMBL29721478 | 0.66 | ROCK1 (0.62) | GRIN1GRIN2BGRIN2DGRIN3BGRIN2A | |
| SCHEMBL6071629 | 0.66 | ROCK1 (0.62) | GRIN1GRIN2BGRIN2DGRIN3BGRIN2A | |
| SCHEMBL1375450 | 0.65 | NPC1 (0.35) | ALDH1A1SMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4388611-A1 | IONIC BINDERS FOR SOLID STATE ELECTRODES | Deakin University (AU) | 2024-06-26 | — | — | EP | disclosed |
| CN-117941116-A | Ionic binders for solid state electrodes | 迪金大学 | 2024-04-26 | — | — | CN | disclosed |
| US-20240084308-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2024-03-14 | — | — | US | disclosed |
| US-20240034845-A1 | POLYMER PARTICLES | QUEENSLAND UNIVERSITY OF TECHNOLOGY (AU) | 2024-02-01 | — | — | US | disclosed |
| EP-3384549-B1 | SODIUM-ION ELECTROLYTE COMPOSITION | UNIV DEAKIN (AU) | 2024-01-17 | — | — | EP | disclosed |
| US-11834663-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2023-12-05 | — | — | US | disclosed |
| US-20230348674-A1 | HYDROGELS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-11-02 | — | — | US | disclosed |
| EP-4225811-A1 | POLYMER PARTICLES | Queensland University Of Technology (AU) | 2023-08-16 | — | — | EP | disclosed |
| US-20230216086-A1 | ELECTROLYTES FOR TARGET ION TRANSPORT | MONASH UNIVERSITY (AU) | 2023-07-06 | — | — | US | disclosed |
| WO-2023121483-A1 | IMMUNOSTIMULATORY COMPOSITIONS | VICTORIA LINK LIMITED (NZ) | 2023-06-29 | — | — | WO | disclosed |
| EP-2106260-A1 | INSULIN SENSITISERS AND METHODS OF TREATMENT | Verva Pharmaceuticals Ltd (AU) | 2009-10-07 | — | — | EP | disclosed |
| CN-101547888-A | Acetylenic compounds | COMMW SCIENT IND RES ORG (AU) | 2009-09-30 | — | — | CN | disclosed |
| WO-2009111830-A1 | CONJUGATED UNSATURATED COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-09-17 | — | — | WO | disclosed |
| WO-2009065169-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE (AU) | 2009-05-28 | — | — | WO | disclosed |
| EP-2059496-A1 | ACETYLENIC COMPOUNDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2009-05-20 | — | — | EP | disclosed |
| WO-2009000049-A1 | INTRINSICALLY CONDUCTING POLYMERS | CRC SMARTPRINT PTY LTD (AU) | 2008-12-31 | — | — | WO | disclosed |
| WO-2008089521-A1 | INSULIN SENSITISERS AND METHODS OF TREATMENT | VERVA PHARMACEUTICALS LTD (AU) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008046155-A1 | METHODS FOR REGULATING GLUCOSE HOMEOSTASIS AND AGENTS THEREFOR | DIA-B TECH LIMITED (AU) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008046156-A1 | VESICULATED POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008031157-A1 | ACETYLENIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2008-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834663-B2 | Fibrotic treatment | MMP1, ENPEP, RNPEP | GRIN1 4457/4885GRIN2B 4518/4885GRIN2D 4855/4885 |
| US-20230348674-A1 | HYDROGELS | PHYKPL, TST, PHOSPHO1 | GRIN1 2118/4885GRIN2B 3032/4885GRIN2D 2830/4885 |
| US-20240084308-A1 | FIBROTIC TREATMENT | MMP1, ENPEP, RNPEP | GRIN1 4457/4885GRIN2B 4518/4885GRIN2D 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.